Screener
Neurocrine Biosciences NBIX Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $144.4M+34.3% | $197.9M+2,405% | $153.7M+49.1% | $209.5M+61.4% | $107.5M+65.4% | ||
| $8.4M+33.3% | $7.2M+9.1% | $6.4M+3.2% | $6.7M+19.6% | $6.3M-1.6% | ||
| $65M+23.1% | $57.2M+8.3% | $58.6M-11.7% | $53.7M+29.4% | $52.8M+22.5% | ||
| $136.4M+33.7% | $145.8M+125% | $388.4M+60.2% | $227.5M+44.0% | $102M+57.9% | ||
| $7.8M-37.6% | $9.1M-15.0% | $0-100% | $13.2M+63.0% | $12.5M+7.8% | ||
| -$135.4M-367% | -$506.2M-3,665% | -$52.9M+22.5% | -$196.7M— | -$29M-2.8% | ||
| $12M-32.2% | $54M-64.0% | —— | —— | $17.7M— | ||
| —— | -$86.1M+27.0% | —— | —— | -$3.3M+98.9% | ||
| —— | -$446.5M-1,048% | $372.8M+421% | $76.2M-63.6% | $69.9M+127% | ||
| $128.6M+43.7% | $136.7M+153% | $390.8M+66.2% | $214.3M+43.0% | $89.5M+68.9% |
FAQ
- How much cash does Neurocrine Biosciences generate?
- Neurocrine Biosciences (NBIX) generated $898.1M in operating cash flow over the trailing twelve months.
- What is Neurocrine Biosciences's free cash flow?
- After $30.1M of capital expenditures, Neurocrine Biosciences's free cash flow was $870.4M over the trailing twelve months, up 64.6% year over year.
- Where does Neurocrine Biosciences's cash flow data come from?
- Every line is extracted from Neurocrine Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
